Divi’s Laboratories rating – Add: Results beat estimates on all counts
Divi’s Laboratories’ (Divi’s) Q4FY22 performance beat our estimates across parameters. Consolidated revenues grew 40.8% y-o-y to Rs 25.2 bn, Ebitda margin improved 380bps y-o-y to 43.9% and…